Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-14-055323
Filing Date
2014-07-31
Accepted
2014-07-31 11:34:59
Documents
10
Period of Report
2014-07-31

Document Format Files

Seq Description Document Type Size
1 6-K a14-18161_16k.htm 6-K 32419
2 EX-99.1 a14-18161_1ex99d1.htm EX-99.1 2010107
3 EX-99.2 a14-18161_1ex99d2.htm EX-99.2 21345
4 EX-99.3 a14-18161_1ex99d3.htm EX-99.3 31006
5 EX-99.4 a14-18161_1ex99d4.htm EX-99.4 107923
6 GRAPHIC g181611mqi001.jpg GRAPHIC 2866
7 GRAPHIC g181611mqi002.jpg GRAPHIC 2902
8 GRAPHIC g181611moi001.jpg GRAPHIC 3142
9 GRAPHIC g181611moi002.jpg GRAPHIC 2902
10 GRAPHIC g181611mm01i001.jpg GRAPHIC 2155
  Complete submission text file 0001104659-14-055323.txt   2223930
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 141005238
SIC: 2834 Pharmaceutical Preparations